Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TAL Education Group
TAL
|
+$819M |
| 2 |
Trip.com Group
TCOM
|
+$260M |
| 3 |
Netflix
NFLX
|
+$228M |
| 4 |
LendingTree
TREE
|
+$204M |
| 5 |
NetEase
NTES
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$611M |
| 2 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$482M |
| 3 |
Royal Caribbean
RCL
|
+$355M |
| 4 |
Baidu
BIDU
|
+$329M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 35.57% |
| 2 | Communication Services | 17.24% |
| 3 | Healthcare | 14.9% |
| 4 | Technology | 9.45% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Pacira BioSciences
PCRX
$1.02B
| $15.9M | 0.02% |
510,097
+139,935
| +38% | +$4.98M |
|
152
STAAR Surgical
STAA
$1.14B
| $15.9M | 0.02% |
1,071,975
+279,568
| +35% | +$4.37M |
|
153
Exelon
EXC
$46.4B
| $15.8M | 0.02% |
566,611
| – | – |
|
154
BlackLine
BL
$1.76B
| $15.5M | 0.02% |
+395,391
| New | +$14.8M |
|
|
KDNY
155
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $15.4M | 0.02% |
331,347
+122,824
| +59% | +$4.5M |
|
156
Eversource Energy
ES
$27B
| $15.2M | 0.02% |
257,553
+3,320
| +1% | +$196K |
|
157
Ameren
AEE
$29.8B
| $14.8M | 0.02% |
262,190
| – | – |
|
|
ONC
158
BeOne Medicines Ltd
ONC
$36.4B
| $14.7M | 0.02% |
87,417
+166
| +0.2% | +$22.5K |
|
|
EXAS
159
DELISTED
Exact Sciences
EXAS
| $14.6M | 0.02% |
362,293
+76,342
| +27% | +$3.72M |
|
160
Consolidated Edison
ED
$39.8B
| $14.5M | 0.02% |
185,972
| – | – |
|
|
PHD
161
DELISTED
Pioneer Floating Rate Fund
PHD
| $14.4M | 0.02% |
1,236,803
| – | – |
|
|
VAR
162
DELISTED
Varian Medical Systems, Inc.
VAR
| $14.4M | 0.02% |
117,375
| – | – |
|
163
RPM International
RPM
$14.8B
| $14.4M | 0.02% |
+301,184
| New | +$15.3M |
|
164
Stratasys
SSYS
$769M
| $13.4M | 0.02% |
666,051
+205,514
| +45% | +$4.39M |
|
165
Ambarella
AMBA
$3.69B
| $13M | 0.02% |
265,085
+68,548
| +35% | +$3.56M |
|
|
EVF
166
Eaton Vance Senior Income Trust
EVF
$90.3M
| $12.8M | 0.02% |
1,885,000
| – | – |
|
167
WEC Energy
WEC
$35.1B
| $12.8M | 0.02% |
204,107
| – | – |
|
168
Edison International
EIX
$26B
| $12.6M | 0.01% |
197,370
+910
| +0.5% | +$56K |
|
|
NSL
169
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $12.5M | 0.01% |
1,915,000
| – | – |
|
|
NCNA
170
NuCana
NCNA
$5.45M
| $12.1M | 0.01% |
128
+18
| +16% | +$1.71M |
|
171
CEVA Inc
CEVA
$980M
| $11.6M | 0.01% |
321,250
+105,861
| +49% | +$4.31M |
|
172
Weibo
WB
$1.94B
| $11.6M | 0.01% |
96,970
-1,163
| -1% | -$148K |
|
173
Lindblad Expeditions
LIND
$2.24B
| $11M | 0.01% |
1,072,701
| – | – |
|
174
PG&E
PCG
$37.5B
| $10.8M | 0.01% |
244,809
+2,910
| +1% | +$123K |
|
|
AFT
175
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $10.4M | 0.01% |
617,746
| – | – |
|
Similar funds
Baillie Gifford & Co's Q1 2018 Portfolio in Review
As of Q1 2018, Baillie Gifford & Co held 207 positions worth $85.3B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.3%. Baillie Gifford & Co opened 6 new positions and exited 3, leaving the 207-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 36% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q1 2018 buy was Dropbox: 2,185,942 shares worth $68.3M.
- Baillie Gifford & Co added most to TAL Education Group in Q1 2018, an estimated $819M increase.
- Baillie Gifford & Co's biggest Q1 2018 reduction was Amazon, cutting an estimated $611M.
- Baillie Gifford & Co fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $482M.
- Baillie Gifford & Co's ten largest holdings make up 49% of its $85.3B portfolio in Q1 2018.
- Baillie Gifford & Co opened 6 new positions and closed 3 in Q1 2018.
- Baillie Gifford & Co's portfolio value rose 6% quarter-over-quarter to $85.3B.
Based on Baillie Gifford & Co's 13F filing for Q1 2018, filed 10 May 2018.